Quantum Tech Pod Episode 20: Quantum Drug Discovery with POLARISqb CEO Shahar Keinan

By IQT News posted 02 Mar 2022

Quantum Tech Pod Host Chris Bishop today interviews POLARISqb CEO Shahar Keinan

Shahar Keinan is CEO and co-founder at POLARISqb with 15+ years of computational chemistry experience, including the previous 10 years in senior scientific and operational leadership positions. She excels at integrating scientific goals and capabilities with business objectives to craft a cohesive go-to-market strategy.

POLARISqb will revolutionize drug design by joining Quantum Computing with AI and Precision Medicine. The platform will produce up to 100 drug blueprints per year and will compress the lead time for preclinical drug candidates from 5 years to 4 months, enabling real time adaptability to the precision medicine market. POLARISqb will own an IP portfolio of drug assets to license, sell, or develop internally.

Quantum Tech Pod hopes that our conversation with  will make this an interesting, informative and worthwhile talk for you.

Subscribe:

Subscribe to Our Email Newsletter

Stay up-to-date on all the latest news from the Quantum Technology industry and receive information and offers from third party vendors.

  • Forthcoming Events

    • IQT Fall (Quantum Cybersecurity)
      October 25-27, 2022
      New York City | In-Person
      (website forthcoming)
    • IQT The Hague (Quantum Communications)
      February 21-23, 2023
      The Hague | In-Person
      (website forthcoming)
    • IQT Spring (Quantum Enterprise)
      April 18-20, 2023
      San Jose | In-Person
      (website forthcoming)
    • Sponsorship / Speaking:
      info@3drholdings.com
0